share

Benzyl Alcohol, 3,4-Dimethyl-α-[1-(Propylamino)Ethyl]-, Erythro- (8Ci) CAS NO 802552-80-3


Unit Price:

CAS No.:802552-80-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Benzyl Alcohol, 3,4-Dimethyl-α-[1-(Propylamino)Ethyl]-, Erythro- (8Ci) is a specialized chiral amine derivative of benzyl alcohol, identified by CAS NO 802552-80-3. This compound is of significant value as a high-purity pharmaceutical intermediate or building block for the synthesis of complex active molecules. It is primarily required by pharmaceutical R&D and fine chemical synthesis sectors for developing new therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key chiral precursor in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for central nervous system or cardiovascular drugs.
  • Asymmetric Synthesis: Utilized as a building block in stereoselective chemical reactions to create molecules with specific three-dimensional configurations.
  • Medicinal Chemistry Research: Serves as a critical scaffold for drug discovery and lead optimization in research laboratories.
  • Fine Chemical Production: Employed in the multi-step synthesis of complex agrochemicals, dyes, or specialty performance chemicals.
  • Ligand and Catalyst Development: Potential use in the development of chiral ligands or organocatalysts for industrial catalytic processes.

Basic Information

Product Name Benzyl Alcohol, 3,4-Dimethyl-α-[1-(Propylamino)Ethyl]-, Erythro- (8Ci)
CAS No. 802552-80-3
Molecular Formula C14H23NO
Molecular Weight 221.34 g/mol
Synonyms Erythro-3,4-Dimethyl-α-[1-(propylamino)ethyl]benzyl Alcohol; (Erythro)-1-(3,4-Dimethylphenyl)-2-(propylamino)-1-propanol; 1-(3,4-Dimethylphenyl)-2-(propylamino)propan-1-ol (erythro-); Benzyl alcohol, 3,4-dimethyl-α-[1-(propylamino)ethyl]-, erythro-; 802552-80-3; (1R*,2S*)-1-(3,4-Dimethylphenyl)-2-(propylamino)propan-1-ol
EINECS Contact for details

Quality Control

Our Benzyl Alcohol, 3,4-Dimethyl-α-[1-(Propylamino)Ethyl]-, Erythro- (8Ci) is produced under a strict quality management system. Every batch undergoes comprehensive analytical testing, including chiral purity analysis by HPLC, to ensure it meets the exacting standards required for pharmaceutical development. Certificates of Analysis (COA) with detailed chromatographic data are provided for full traceability and regulatory support.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). This material is moisture-sensitive (hygroscopic); keep the container tightly sealed under an inert atmosphere (e.g., nitrogen) for long-term storage to prevent degradation.

Specification

Item Specification
Appearance White to off-white crystalline powder or solid
Identification (IR) Conforms to structure
Assay (HPLC) ≥ 98.0%
Chiral Purity (HPLC) ≥ 99.0% (Erythro isomer)
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.